У нас вы можете посмотреть бесплатно Behind the Study: ER Expression Multiclonality in DCIS: Clinical & Future Insights | Oncotarget или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Dr. Mangesh A. Thorat from Guy’s Hospital in London, Queen Mary University of London, and King’s College London, describes a recent #editorial he authored that was #published by Oncotarget in Volume 14, entitled, “Multiclonality of ER expression in DCIS – Implications for clinical practice and future research.” @GSTTnhs @QMUL @kingscollegelondon #author #interview #authorinterview #researcher #cancer #cancerresearch #breastcancer #research #recurrence #clonality #ER #openaccess #openscience #peerreview #journal #publication #meded #publishing DOI - https://doi.org/10.18632/oncotarget.2... Correspondence to - Mangesh A. Thorat - [email protected]; [email protected] Video transcript - https://www.oncotarget.net/2023/08/29... Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/deta... Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, ductal carcinoma in situ (DCIS), invasive breast cancer, ER, recurrence, clonality About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: SoundCloud - / oncotarget Facebook - / oncotarget Twitter - / oncotarget Instagram - / oncotargetjrnl YouTube - / @oncotargetjournal LinkedIn - / oncotarget Pinterest - / oncotarget Reddit - / oncotarget Media Contact [email protected] 18009220957